paripartum cardiomyopathy, PPCM, pregnancy
Peripartum cardiomyopathy (PPCM), the fifth leading cause of death in pregnancy, is often overlooked or misdiagnosed because of vague symptoms and a lack of specific criteria for diagnosis. The authors performed a literature review of articles published between January 2000 and November 2007, and found that early diagnosis via echocardiography and interventions with specific treatment modalities can reduce mortality. Dobutamine stress testing may be prognostic for left ventricular (LV) dysfunction. Standard heart failure (HF) drug regimens, heart transplantation, and mechanical assist devices are viable treatment modalities, depending on individual needs. Subsequent pregnancies must be followed closely. The authors recommend that nurse practitioners (NPs) be vigilant when assessing patients for PPCM and refer such patients to specialists as soon as possible.
Original Publication Citation
Goss, J. A., Bond, A. E., Beckstrand, R. L., & Callister, L. (2008). Peripartum cardiomyopathy: an integrative literature review. American Journal for Nurse Practitioners, 12(5), 49-55.
BYU ScholarsArchive Citation
Goss, Jeffrey A.; Bond, A. Elaine; Beckstrand, Renea L.; and Callister, Lynn C., "Paripartum Cardiomyopathy: Implications for NPs" (2008). Faculty Publications. 5305.
The American Journal for Nurse Practitioners
Copyright Use Information